SpringWorks Therapeutics Inc SWTX:NASDAQ

RT Quote | NASDAQ | USD
Last | 10/04/22 EDT
28.22quote price arrow up+1.19 (+4.40%)
Volume
693,671
52 week range
13.60 - 77.70
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close28.22
  • 52 Week High77.70
  • 52 Week High Date11/09/21
  • 52 Week Low13.60
  • 52 Week Low Date05/27/22

Key Stats

  • Market Cap1.395B
  • Shares Out49.44M
  • 10 Day Average Volume0.82M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-54.47

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close28.22
  • 52 Week High77.70
  • 52 Week High Date11/09/21
  • 52 Week Low13.60
  • 52 Week Low Date05/27/22
  • Market Cap1.395B
  • Shares Out49.44M
  • 10 Day Average Volume0.82M
  • Dividend-
  • Dividend Yield-
  • Beta0.79
  • YTD % Change-54.47

RATIOS/PROFITABILITY

  • EPS (TTM)-4.66
  • P/E (TTM)-6.05
  • Fwd P/E (NTM)-5.29
  • EBITDA (TTM)-226.608M
  • ROE (TTM)-55.44%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-304.47%
  • Debt To Equity (MRQ)1.78%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SpringWorks Therapeutics Inc

 

Profile

MORE
SpringWorks Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on acquiring, developing and commercializing medicines for underserved patient populations suffering from devastating rare diseases and cancer. It has a portfolio of small molecule targeted oncology product candidates and are advancing two clinical trials in rare tumor types, as well as other programs addressing genetically defined cancers. Its product candidate is...
Daniel Lynch
Non-Executive Independent Chairman of the Board
Saqib Islam J.D.
Chief Executive Officer, Director
Badreddin Edris Ph.D.
Chief Operating Officer
Francis Perier Jr.
Chief Financial Officer
Herschel Weinstein J.D.
General Counsel, Secretary
Address
100 Washington Blvd
Stamford, CT
06902-9302
United States

Top Peers

SYMBOLLASTCHG%CHG
PCVX
Vaxcyte Inc
23.57-0.66-2.72%
CLDX
Celldex Therapeutics Inc
28.54+0.76+2.74%
IOVA
Iovance Biotherapeutics Inc
10.00+0.66+7.07%
AKRO
Akero Therapeutics Inc
38.46+5.02+15.01%
RVMD
Revolution Medicines Inc
20.00+0.47+2.41%